SGMO Retrace

Sangamo Therapeutics, Inc.NASDAQ

Descripción

⋅ 2 de Jul. de 2019 2:19

SGMO will retrace slightly before its FDA approval, still trading above 100 EMA, MFI/RSI cooling off.